Newsletter | March 15, 2024

03.15.24 -- Tangential Flow Filtration 101 — The Tech, The Need, And The Market

SPONSOR

What analytics technologies, tools, and instruments do biopharma developers consider requisite in the buildout of a modern biologics/ATMP, manufacturing facility? How are those tools enabling the analytics and controls that are requisite to continuous manufacturing and advancing the industry toward “biopharma 4.0?” Join Bioprocess Online Live on March 27th to find out! Registration is free thanks to the support of Culture Bio.

FEATURED EDITORIAL

Tangential Flow Filtration 101 — The Tech, The Need, And The Market

Here's a high-level summary of what is increasingly becoming an essential part of the downstream bioprocessing production line.

Doubling Down On Biopharma’s Growing Skills Drought

The biopharma industry is building manufacturing capacity at breakneck speed. According to PhRMA, there are 1,580-and-counting biopharma manufacturing facilities in the U.S. alone. Problem is, we're way short on filling those facilities with skilled labor. NIIMBL wants to change that. Here's how, and a great opportunity for big pharma, biotech sponsors, CDMOs, academics, and more to help.

INDUSTRY INSIGHTS

Selecting The Right Single-Use Materials In Biopharmaceutical Manufacturing

Manufacturing operations are getting a boost thanks to single-use technologies, but how do biopharmaceutical manufacturers choose the right materials for constructing their single-use solutions?

mRNA: How To Build A Custom Program Using CDMO Services

Development of RNA-based therapies sits at the cutting edge of vaccine and oncology innovation, in addition to holding promise in dozens of other therapeutic areas.

Move Your Gene Therapy From Strategy To Reality

Implementing integrated solutions can provide cell and gene therapy manufacturing systems that work in concert to create a closed, automated, scalable, and performance-qualified network of unit operations.

Improve Biopharma Fermentation With Innovation, Collaboration

Organizations developing products requiring fermentation often create custom processes from scratch, leaving room for inefficiencies, lost value, and, in the case of significant error, costly time delays.

Leveraging ISA-95 In A Pharma 4.0 World

Explore core elements of the ISA-95 specification and how life sciences manufacturers can apply them within an integration solution designed for industrial data modeling, delivery, and governance.

Most Common Questions About Combination Connectors

This article provides insight on why combination connections are used in single-use bioprocessing and guidance on how single-use systems can be designed to integrate the combination connectors.

Understanding The Cold Durability Performance Of Fluoropolymer Bags

Although polymer bags are an excellent choice for cold chain use, not all polymer films perform the same way, even if their specifications rate them for use at low temperatures.

Three Benefits Of Partnering With A CDMO For CGT Manufacturing

By leveraging the capabilities of a CDMO, pharmaceutical companies can focus on their core competencies and accelerate the development and delivery of life-saving therapies to patients.

Recommendations For Successful IND Approval Of RNA-LNP Drugs

The existing regulatory system is ambiguous for RNA therapeutics. Leverage this investigational new drug (IND) guide to help accelerate and strengthen the IND process filing of novel nanomedicines.

How Digital Technology Accelerates Your Move To Proactive Quality

AI is dramatically reshaping the manufacturing environment. Explore a proactive approach to digitizing technology, plus an integrated digital strategy for workforce management and much more.

Complexities And Pitfalls Associated With cGMP Tissue Sourcing

Review the elements of a complex process, prone to misconceptions and pitfalls, to find the “right human tissue” that will yield the desired cell quality and quantity and pass BLA approval.

SPONSOR

Webinar: Expediting Biologics Drug Development: Downstream Strategies To Accelerate Preclinical Development Timelines

Join us as we explore the utilization of historical data in downstream processes to expedite rapid process development, discuss the implementation of effective strategies to shorten the timeline in technology transfer processes, and analyze case studies demonstrating the successful application of bispecific antibodies as demonstrated in real-world scenarios. Click here to learn more.

SOLUTIONS

Reliable BioProcessing Check Valves

GMP Manufacturing

Biochemical Test Kits: LabAssay Series

Automatic, Multiplexed Digital PCR With The QX ONE ddPCR System

Versatile Volume Verification System For All Your Liquid Handling Needs

Scientific Insights Lab Simplifying The Journey From Molecule To Market

Connect With Bioprocess Online: